Purchase Order VA648D95036

Bioreliance Corporation, a Life Sciences Services division of Sigma-Aldrich Corporation, received a Blanket Purchase Agreement (BPA) call award from the National Cancer Institute on March 13, 2014, with a ceiling value of $3,218. The contract, which was not set aside for any specific business category, was awarded on a firm fixed-price basis for performance in Bethesda, Maryland, with an ultimate completion date of April 30, 2014. As a subsidiary of Sigma-Aldrich Corporation, Bioreliance brought...

BioReliance Corporation, a Life Sciences Services division of Sigma-Aldrich Corporation, received a Blanket Purchase Agreement (BPA) call award from the National Cancer Institute valued at $3,474 on August 14, 2014, with a completion date of April 30, 2015. The contract, which was not set aside for any specific business category, operates on a firm fixed-price basis and is to be performed at the contractor's facility in Bethesda, Maryland. BioReliance specializes in critical laboratory and...

The National Cancer Institute awarded a $4.8K firm fixed-price BPA (Blanket Purchase Agreement) call to Bioreliance Corporation on August 12, 2014, with completion targeted for April 30, 2015. The work will be performed at the agency's Bethesda, Maryland location. Bioreliance Corporation, a subsidiary of Sigma-Aldrich Corporation, operates its Life Sciences Services division from Rockville, Maryland and specializes in critical laboratory and testing services for federal health research...

Inotiv Inc., doing business as BASi Research Products Division, has been awarded a $12,000 firm fixed price purchase order by the Environmental Protection Agency Office of Research and Development to provide non-GLP Ames assay services. The place of performance will be in West Lafayette, Indiana and the period of performance is expected to conclude on February 18, 2025. As a manufacturer of goods and provider of drug discovery and development services to the global pharmaceutical industry,...

This is a Definitive Contract awarded by the U.S. government to Bioo Scientific Corporation, a small business entity, for the development of molecular pharmacodynamic assays under the SBIR (Small Business Innovation Research) Program Phase I. The contract, valued at $147,500.00, was awarded on September 30, 2008 with a period of performance from September 29, 2008 to March 28, 2009. The contract was set aside for total small business participation and the place of performance was in Austin,...

This is a delivery order contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Bioreliance Corporation, a foreign-owned, for-profit company providing specialized testing services. The $127,772.70 firm-fixed-price contract is for biosafety testing of a 293GP master cell bank used for production of patient-specific gammaretroviral vectors encoding TCRs directed against tumor neoantigens. The contract does not have a set-aside...

The National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $91,832.29 firm-fixed-price delivery order to Bioreliance Corporation, a foreign-owned, for-profit organization, for sterility testing services. The contract has no set-aside designation. Bioreliance's Life Sciences Services division, doing business as Bioreliance Corp De, has extensive experience providing specialized testing services such as endotoxin, sterility, and...

This is a $50,000.00 firm-fixed-price purchase order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for testing of chemical compounds in a human neurite outgrowth assay as part of absorption, distribution, metabolism, and excretion (ADME) and toxicology (ADME-TOX) services. Cyprotex has significant expertise in predictive toxicology, ADME research, and in...

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization. The contract is for a Sterility Assay, Line Item 119 and has a firm fixed price of USD 36,008.23. The contract was awarded on January 18, 2013 with a completion date of June 30, 2013. The place of performance is Potomac, MD. Bioreliance Corporation, through its Life Sciences...

This contract award to Gempharmatech LLC, a foreign-owned biotechnology company in San Diego, California, is for a $58,936 fixed-price purchase order to evaluate the safety of the compound YC1 in mice with humanized SULT1A1 proteins versus standard mouse SULT1A1 proteins. The contract was awarded by the National Center for Advancing Translational Sciences (NCATS), which operates under the National Institutes of Health within the Department of Health and Human Services. The objective is to...